Skip to Content

Lyrica Pfizer Inc. - Treatment for Neuropathic Pain

Lyrica is a 3-substituted analogue of gamma-amino butyric acid (GABA) and a compound related to gabapentin (Neurontin). Lyrica is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN).

Posted: December 2004

Related Articles:

Lyrica (pregabalin) FDA Approval History